Managing Your Lipid Levels
At a Glance
Hepatic lipase deficiency has no established LIPC-specific cure, so management is individualized. A heart-healthy or clinician-prescribed low-fat diet, activity, alcohol avoidance, appropriate medicines, and regular lipid testing help lower triglycerides and protect heart health.
Because hepatic lipase deficiency is exceptionally rare, there is no single medication or “cure” designed specifically for the LIPC gene, and controlled treatment data are very limited [1][2]. Instead, management focuses on a personalized strategy to lower your triglycerides and protect your heart using the same proven tools used for general primary hypertriglyceridemia disorders [3].
Lifestyle: The Foundation of Care
In genetic lipid conditions, lifestyle changes aren’t just “good advice”—they are the primary way to manage the fat particles your body cannot process on its own [3]. Dietary goals depend strongly on your current triglyceride levels.
- Dietary Fat and Carbohydrate Control:
- Moderate Elevations (Under 500 mg/dL): The focus is on a heart-healthy pattern emphasizing unsaturated fats, fiber, weight management when appropriate, and limited refined carbohydrates.
- Severe Elevations (500 to >1,000 mg/dL): Very strict limits on total fat (e.g., 20 grams per day) may be temporarily or continuously prescribed by a clinician to prevent pancreatitis. Note: A very-low-fat diet is not automatically appropriate for moderate elevations and can lead to nutritional inadequacy or an over-reliance on refined carbohydrates if unsupervised. [4][5].
- Limit Simple Sugars: Your liver turns excess sugar and refined carbohydrates (like white bread, pasta, and sweets) into triglycerides. Replacing these with fiber-rich whole grains and proteins can significantly lower your numbers [6][7][8].
- Weight and Activity: Optimizing your weight and staying physically active helps your body use fats more efficiently for energy [8][3]. Aiming for moderate-intensity exercise most days of the week is a standard recommendation for heart health [6][9].
- Alcohol Restriction: Alcohol is a major “secondary driver” that tells your liver to pump out more triglycerides. Avoidance of alcohol is a common recommendation, especially if triglycerides are elevated [8][10].
Pharmacologic Therapy
While lifestyle is first-line, many people with hepatic lipase deficiency also require medications to reach their health goals. Do not start, stop, or change these medicines without your prescriber.
1. Triglyceride-Lowering Medications
If your triglycerides remain substantially elevated despite diet changes, your doctor may consider:
- Fibrates: These medications (such as fenofibrate) may be considered to lower triglycerides to reduce pancreatitis risk [11][12]. Treatment must account for your kidney function, liver disease, gallstones, and potential interactions with statins.
- Omega-3 Fatty Acids: The product and dose must be clinician-selected. Prescription omega-3s are not interchangeable with over-the-counter supplements. While some can lower triglycerides, certain products can raise LDL-C or affect bleeding/atrial-fibrillation risk [11][6].
2. Statins for Heart Protection
Even though the main problem in this condition is the hepatic lipase enzyme, you may still be prescribed a statin. Statins are not a treatment for the missing enzyme itself; rather, their use is based on your LDL-C, apoB, diabetes, established ASCVD, age, and overall risk [3][13]. Discuss pregnancy plans, renal/hepatic disease, and adverse effects before starting or combining lipid medicines.
Managing “Secondary Drivers”
Your genetic makeup is constant, but other factors can “unmask” or worsen the deficiency. Managing these secondary drivers is a critical part of your treatment plan [3]:
- Blood Sugar Control: If you have diabetes or prediabetes, keeping your blood sugar in a healthy range is one of the most effective ways to keep your triglycerides low [8][14].
- Medication Review: Some common drugs (like certain blood pressure pills, steroids, or estrogens) can raise triglycerides. Your doctor may look for alternatives that are “lipid-neutral” [10].
- Thyroid and Kidney Health: Ensuring your thyroid and kidneys are functioning well helps ensure your body is clearing fats as effectively as possible [15].
Because your phenotype (how the disease shows up in your blood) is unique, your “best” treatment will be found through regular testing and close collaboration with your medical team [16][17].
Common questions in this guide
What is the usual treatment for hepatic lipase deficiency?
Do I need a very-low-fat diet if I have hepatic lipase deficiency?
Can fenofibrate or omega-3 fatty acids help lower triglycerides with hepatic lipase deficiency?
Why might I need a statin if I have hepatic lipase deficiency?
What can make my triglycerides worse despite the genetic condition?
How often should my cholesterol and triglycerides be checked?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Hyperlipidemia due to hepatic triacylglycerol lipase deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current triglyceride levels, what specific daily fat limit (in grams) do you recommend for my diet?
- 2.Given that there is no LIPC-specific drug, what are our 'target numbers' for my triglycerides and LDL cholesterol?
- 3.If we start a fibrate or high-dose omega-3, how soon should we re-test my levels to see if they are working?
- 4.Can you review my other medications to see if any of them are 'unmasking' my genetic deficiency by raising my triglycerides?
- 5.Should I see a specialized dietitian to help me design a low-fat meal plan that still meets my nutritional needs?
References
References (17)
- 1
Hepatic Lipase: a Comprehensive View of its Role on Plasma Lipid and Lipoprotein Metabolism.
Kobayashi J, Miyashita K, Nakajima K, Mabuchi H
Journal of atherosclerosis and thrombosis 2015; (22(10)):1001-11 doi:10.5551/jat.31617.
PMID: 26194979 - 2
PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes.
Hess CN, Low Wang CC, Hiatt WR
Annual review of medicine 2018; (69()):133-145 doi:10.1146/annurev-med-042716-091351.
PMID: 29095667 - 3
Primary hypertriglyceridemia in children and adolescents.
Shah AS, Wilson DP
Journal of clinical lipidology 2015; (9(5 Suppl)):S20-8.
PMID: 26343209 - 4
Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
Williams L, Rhodes KS, Karmally W, et al.
Journal of clinical lipidology 2018; (12(4)):908-919 doi:10.1016/j.jacl.2018.04.010.
PMID: 29804909 - 5
Silencing Triglycerides: The Clinical Impact of Plozasiran and apoC-III Inhibition in Severe Hypertriglyceridemia.
Kassem BA, Shaik FA, Sorour O, et al.
Journal of cardiovascular pharmacology 2026; (88(2)):123-131 doi:10.1097/FJC.0000000000001846.
PMID: 42359618 - 6
Management of Hypertriglyceridemia: Common Questions and Answers.
Oh RC, Trivette ET, Westerfield KL
American family physician 2020; (102(6)):347-354.
PMID: 32931217 - 7
The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.
Luna-Castillo KP, Olivares-Ochoa XC, Hernández-Ruiz RG, et al.
Nutrients 2022; (14(5)) doi:10.3390/nu14051104.
PMID: 35268076 - 8
The Diagnosis and Treatment of Hypertriglyceridemia.
Parhofer KG, Laufs U
Deutsches Arzteblatt international 2019; (116(49)):825-832.
PMID: 31888796 - 9
Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease.
Wang Y, Shen L, Xu D
Clinical cardiology 2019; (42(1)):56-61 doi:10.1002/clc.23104.
PMID: 30511426 - 10
Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
Falko JM
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(8)):756-763 doi:10.4158/EP-2018-0157.
PMID: 30183397 - 11
Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy.
Reiner Ž
Korean circulation journal 2018; (48(12)):1097-1119 doi:10.4070/kcj.2018.0343.
PMID: 30403015 - 12
Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome.
Chaudhry R, Viljoen A, Wierzbicki AS
Expert review of clinical pharmacology 2018; (11(6)):589-598 doi:10.1080/17512433.2018.1480368.
PMID: 29842811 - 13
Phenotype in Individuals with Heterozygous Rare Variants in LIPC Encoding Hepatic Lipase.
Jacob EO, Wang J, McIntyre AD, Hegele RA
International journal of molecular sciences 2024; (25(21)) doi:10.3390/ijms252111445.
PMID: 39518997 - 14
Approach to the Patient With Moderate Hypertriglyceridemia.
Subramanian S
The Journal of clinical endocrinology and metabolism 2022; (107(6)):1686-1697 doi:10.1210/clinem/dgac085.
PMID: 35184196 - 15
Insulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans.
Labadzhyan A, Cui J, Péterfy M, et al.
PloS one 2016; (11(11)):e0166263 doi:10.1371/journal.pone.0166263.
PMID: 27846285 - 16
High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.
Tani M, Horvath KV, Lamarche B, et al.
Atherosclerosis 2016; (253()):7-14 doi:10.1016/j.atherosclerosis.2016.08.014.
PMID: 27573733 - 17
Can genetic testing help in the management of dyslipidaemias?
Lazarte J, Hegele RA
Current opinion in lipidology 2020; (31(4)):187-193 doi:10.1097/MOL.0000000000000690.
PMID: 32520779
This page is for informational purposes only and does not constitute medical advice. Do not change your diet, exercise plan, or lipid medicines without guidance from your clinician or a qualified dietitian.